SCHEMBL6031015

SCHEMBL6031015

CC(C)(C)OC(=O)N1CCC2(CC1)c1ccccc1CCn1c(Cl)cnc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.50
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
KDM1A O60341 4/20 0.42
POLB P06746 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
ESR2 Q92731 1/20 0.40
NR1H2 P55055 1/20 0.40
AVPR1A P37288 1/20 0.39
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
CKS1B P61024 1/20 0.38
SKP1 P63208 1/20 0.38
SKP2 Q13309 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
PDK2 Q15119 1/20 0.38
CYP11B2 P19099 1/20 0.38
NAMPT P43490 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6030115 0.89 HRH1 (0.51) HRH1OPRD1OPRK1KDM1AESR2
SCHEMBL6031742 0.87 HRH1 (0.56) HRH1OPRD1OPRK1KDM1ANR1H2
SCHEMBL6031453 0.87 HRH1 (0.67) HRH1OPRD1OPRK1KDM1AESR2
SCHEMBL6030029 0.87 HRH1 (0.56) HRH1OPRD1OPRK1KDM1AESR2
SCHEMBL6031091 0.87 HRH1 (0.48) HRH1OPRD1OPRK1KDM1APOLB
SCHEMBL7886802 0.82 HRH1 (0.50) HRH1OPRK1MAPK1
SCHEMBL6030481 0.80 OPRD1 (0.42) HRH1OPRD1OPRK1KDM1AESR2
SCHEMBL6030737 0.80 OPRD1 (0.55) HRH1OPRD1OPRK1KDM1APOLB
SCHEMBL6030027 0.80 HRH1 (0.56) HRH1OPRD1OPRK1KDM1AESR2
SCHEMBL6030410 0.79 HRH1 (0.44) HRH1OPRD1OPRK1KDM1AESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7148214-B1 Antihistaminic spiro compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2006-12-12 US disclosed
US-7087595-B2 Antihistaminic spiro compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2006-08-08 US disclosed
EP-1144411-B1 ANTIHISTAMINIC SPIRO COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2005-04-27 EP disclosed
US-20050026901-A1 Antiallergens; vision disorders JANSSENS FRANS EDUARD (BE) 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026901-A1 Antiallergens; vision disorders UACA, LTB4R, HLA-B HRH1 35/4885OPRD1 1139/4885OPRK1 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.